RA-Map Early Rheumatoid Arthritis patient genotyping (InfiniumCoreExome-24-v1)
Genotyping of 244 early RA patients and 44 vaccine recipient controls was performed using the Illumina InfiniumCoreExome-24-v1-1 according to the manufacturer’s SOP. Raw idats from the Illumina iScan instrument were imported into GenomeStudio (v2011.1). Samples < 90 % call rate were excluded. Data was exported to PLINK PED/MAP format on the forward strand. Data was converted from PED/MAP to BED/BIM/FAM using PLINK v1.07.
- 10/12/2020
- 276 samples
- DAC: EGAC00001001589
DUO:0000005 version: 2019-01-07
general research use and clinical care
This data use limitation indicates that use is allowed for health/medical/biomedical purposes and other biological research, including the study of population origins or ancestry.
DUO:0000014 version: 2019-01-07
research use only
This data use limitation indicates that use is limited to research purposes (e.g., does not include its use in clinical care).
DUO:0000019 version: 2019-01-07
publication required
This data use modifier indicates that requestor agrees to make results of studies using the data available to the larger scientific community.
DUO:0000028 version: 2019-01-07
institution specific restriction
This data use modifier indicates that use is limited to use within an approved institution.
Data provided is on condition of full attribution of the RA-Map consortium in acknowledgment, in adherence to the RA-MAP Consortium’s publication policy. Data should not be passed to third parties, all results relating to RA-Map subjects should be shared with the RA-MAP consortium.
Data provided is on condition of full attribution of the RA-Map consortium in acknowledgment, in adherence to the RA-MAP Consortium’s publication policy. Data should not be passed to third parties, all results relating to RA-Map subjects should be shared with the RA-MAP consortium. RA-MAP Consortium’s publication policy All publications relating to this data should include the following acknowledgement "genotype data was funded by the MRC/ABPI Inflammation and Immunology Initiative Grant (MRC reference numbers: G1001516 and G1001518).
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
| Study ID | Study Title | Study Type |
|---|---|---|
| EGAS00001004424 | Other |
This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.
| ID | File Type | Size | Quality Report |
Located in
i
|
|---|---|---|---|---|
| EGAF00004940658 | vcf | 232.6 MB |
|
|
| 1 File (232.6 MB) | ||||
